Cost-efficacy of biologic therapies for psoriatic arthritis from the perspective of the Taiwanese healthcare system.

Abstract

BACKGROUND Biologic therapies are more effective but more costly than conventional therapies in treating psoriatic arthritis. OBJECTIVES To evaluate the cost-efficacy of etanercept, adalimumab and golimumab therapies in treating active psoriatic arthritis in a Taiwanese setting. METHODS We conducted a meta-analysis of randomized placebo-controlled… (More)
DOI: 10.1111/1756-185X.12744

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.